Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,191.14

7.48 (0.63%)

, GOOGL

Alphabet Class A

$1,193.76

5.67 (0.48%)

13:26
03/19/19
03/19
13:26
03/19/19
13:26

Game publishers rise following Google's Stadia announcement

Shares of several video game makers rose following Google's (GOOG) announcement of new gaming platform Stadia, a service that allows player to stream high-octane games on any device with the press of a button on Chrome. After the announcement, Activision Blizzard (ATVI) was up 4.7%, Take-Two (TTWO) was 2.8% higher, and Ubisoft (UBSFY) was up 0.8% in New York.

GOOG

Alphabet

$1,191.14

7.48 (0.63%)

GOOGL

Alphabet Class A

$1,193.76

5.67 (0.48%)

ATVI

Activision Blizzard

$46.80

1.83 (4.07%)

TTWO

Take-Two

$95.98

2.22 (2.37%)

UBSFY

Ubisoft

$0.00

(0.00%)

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

GOOG Alphabet
$1,191.14

7.48 (0.63%)

03/07/19
MSCO
03/07/19
NO CHANGE
Target $300
MSCO
Overweight
Arista Networks price target raised to $300 from $265 at Morgan Stanley
Morgan Stanley analyst James Faucette said he has increased confidence in Arista Networks' (ANET) ability to beat consensus estimates as he believes Arista is likely to benefit from hyperscale customers' growth. Faucette explains that he sees Arista sales as most closely tied to hyperscale service revenue and he believes better than expected revenue at Microsoft (MSFT), Google (GOOGL) and Facebook (FB) will lead to better than expected buying of Arista gear. Given that view and his confidence, Faucette raised his price target on Arista shares to $300 from $265 and keeps an Overweight rating on the stock.
03/05/19
RSBL
03/05/19
NO CHANGE
Target $212
RSBL
Buy
Rosenblatt sees low odds Facebook would be forced to spin off Instagram
Though it is possible a new task force announced last week by the FTC may consider unwinding consummated M&A by internet companies, presumably including Facebook (FB) and Instagram, Rosenblatt analyst Mark Zgutowicz sees a low probability of such a forced spinoff for two primary reasons. First, spinning off Instagram would not necessarily make the social media market more competitive. Second, it may be hard to prove how such a theoretical breakup would better protect user privacy. In such a scenario, he sees potential for 13% downside to Facebook shares if the company were to be forced to spinout Instagram due to the added costs of running two separate companies. Zgutowicz said he remains an aggressive buyer of Facebook shares, despite the FTC task force that appears directed at mega cap tech companies including it, Google (GOOGL) and Amazon (AMZN), given the social media company's stable fundamentals and an accelerating earnings growth profile. Zgutowicz keeps a Buy rating and $212 price target on Facebook.
03/05/19
03/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) initiated with a Buy at Needham. 2. Lennox (LII) initiated with a Neutral at Goldman Sachs. 3. Aurora Cannabis (ACB) initiated with an Outperform at Cowen. 4. Floor & Decor (FND) initiated with an Outperform at Baird. 5. Gossamer Bio (GOSS) initiated with an Outperform at Evercore ISI and SVB Leerink, an Overweight at Barclays, and a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/19
COWN
03/06/19
DOWNGRADE
Target $40
COWN
Underperform
TripAdvisor downgraded to Underperform on weak 2019 start at Cowen
As reported previously, Cowen analyst Kevin Kopelman downgraded TripAdvisor (TRIP) to Underperform from Market Perform. The analyst cited a weak start to 2019, expectations for weaker usage, and worries about younger age demos using Google (GOOG). He expects profit growth to slow to single digits by 2020 and thinks the stock's multiple should now be more in line with peers. Kopelman lowered his price target to $40 from $50 on TripAdvisor shares.
GOOGL Alphabet Class A
$1,193.76

5.67 (0.48%)

ATVI Activision Blizzard
$46.80

1.83 (4.07%)

03/15/19
PIPR
03/15/19
NO CHANGE
Target $52
PIPR
Overweight
Activision worth a look after 50% drop in six months, says Piper Jaffray
Activision Blizzard shares are down nearly 50% in the past six months and investors should be "kicking the tires," given an improving setup in late 2019 and 2020, Piper Jaffray analyst Michael Olson tells investors in a research note. The analyst sees five reasons to do the work on Activision, including: increasing near-term talk on streaming, potential E3 announcements, anticipation around improving fundamentals in 2020, management's re-allocation of resources towards key franchises, and valuation. While it may still be early with a lack of new game catalysts in 2019, patient investors should consider "chipping away at a position" in the stock at current levels, Olson writes. He maintains an Overweight rating on Activision Blizzard with a $52 price target.
02/19/19
STFL
02/19/19
NO CHANGE
Target $52
STFL
Buy
Activision Blizzard price target lowered to $52 from $57 at Stifel
Stifel analyst Drew Crum lowered his estimates for Activision Blizzard to reflect more conservative assumptions following the company's mixed Q4 results and weaker than expected 2019 guidance. However, he sees the announced restructuring as necessary and continues to favor the stock for the longer-term. Crum keeps a Buy rating on the shares, but trimmed his price target for Activision Blizzard to $52 from $57.
02/15/19
BMOC
02/15/19
NO CHANGE
Target $40
BMOC
Market Perform
Activision Blizzard price target lowered to $40 from $52 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Activision Blizzard to $40 and kept his Market Perform rating after its significantly-below-consensus FY19 guidance. The analyst notes that while the market was prepared for a weak guide, a wide restructuring plan, and cost reductions through job cuts, he sees the company faced with persisting challenges exacerbated by "a sparse release slate and demoralized workforce." Johnson recommends that investors "resist the urge to call this a bottom" after the stock was bid up by over 10% from this week's low above $45 per share.
03/19/19
MSCO
03/19/19
NO CHANGE
Target $55
MSCO
Overweight
Morgan Stanley lays out ways Call of Duty Mobile matters for Activision Blizzard
After Activision Blizzard announced that "Call of Duty: Mobile" will be launching in the Americas, Europe and elsewhere with a public beta coming this summer, Morgan Stanley analyst Brian Nowak listed four reasons he sees for why the game "matters." Namely, he sees CoD: Mobile as a way for the company to capitalize on its leading intellectual property in the rapidly growing free-to-play and mobile markets; he noted that there are multiple annual billion dollar revenue games in China alone, noting that even a $500M revenue mobile franchise would add 9% to 2020 EPS; he said he doesn't have the game in his model, meaning its "all optionatlity"; and he views the game as another opportunity to prove Call of Duty is still a AAA franchise. Nowak keeps an Overweight rating and $55 price target on Activision Blizzard shares.
TTWO Take-Two
$95.98

2.22 (2.37%)

02/13/19
SPHN
02/13/19
NO CHANGE
Target $57
SPHN
Overweight
Activision Blizzard transition year creates buying opportunity, says Stephens
Stephens analyst Jeff Cohen noted that Activision Blizzard (ATVI), like peers Electronic Arts (EA) and Take-Two (TTWO), gave 2019 guidance that was significantly below consensus and framed it as a transition year. Cohen, who said he feels confident now is the time to be buying as 2019 should represent the trough of earnings power, lowered his price target on the shares to $57 from $65 but keeps an Overweight rating on Activision Blizzard shares.
02/12/19
02/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BHP Billiton (BHP) downgraded to Neutral from Buy at Goldman Sachs. 2. Gilead (GILD) downgraded to Neutral from Buy at Citi and to Market Perform from Outperform at Wells Fargo. 3. Cisco (CSCO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Cisco's multiple has meaningfully expanded over the past 1.5 years as estimates and expectations have built in a likely benefit from security-driven networking. 4. Take-Two (TTWO) downgraded to Underperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying that after a 2-year "hype machine" blast for its Red Dead Redemption 2 title and its "strong" premier, the buzz around the game has "dissipated markedly." 5. Fastenal (FAST) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying he continues to view the company as a "best-in-class" distributor with a "sizable first-mover advantage" in OnSite and Vending, but he finds the stock's risk/reward as more balanced near his prior price target of $62. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/19
02/12/19
DOWNGRADE
Target $80

Underperform
Take-Two downgraded to Underperform at BMO Capital on dissipating RDR2 'buzz'
As previously reported, BMO Capital analyst Gerrick Johnson downgraded Take-Two to Underperform from Market Perform and cut his price target to $80 from $119. The analyst notes that after a 2-year "hype machine" blast for its Red Dead Redemption 2 title and its "strong" premier, the buzz around the game has "dissipated markedly." Johnson is concerned that game engagement may lapse and the company's ability to monetize the release to "desired levels" may be pressured. The analyst adds that lackluster results by videogame companies have caught up with their high valuations, sending the sector down since the fall. and sees Take-Two as not being immune to the broader downturn.
02/12/19
BMOC
02/12/19
DOWNGRADE
BMOC
Underperform
Take-Two downgraded to Underperform from Market Perform at BMO Capital
UBSFY Ubisoft
$0.00

(0.00%)

01/10/19
SPHN
01/10/19
INITIATION
SPHN
Equal Weight
Ubisoft initiated with an Equal Weight at Stephens
Stephens analyst Jeff Cohen started Ubisoft with an Equal Weight rating and EUR 75 price target. Uncertainty around the company's fiscal 2020 slate increases risk that unit sales could be down year-on-year, Cohen tells investors in a research note. Further, he believes Ubisoft's further margin expansion will be slower than what is being priced into shares.
01/11/19
01/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Activision Blizzard (ATVI), Take-Two (TTWO), Electronic Arts (EA), Glu Mobile (GLUU) were initiated with an Overweight at Stephens, while the analyst also initiated Zynga (ZNGA) and Ubisoft (UBSFY) with an Equal Weight. 2. Domino's Pizza (DPZ) initiated with an Outperform at Cowen. 3. Okta (OKTA) and Zscaler (SZ) initiated with an Overweight at Piper Jaffray. 4. Lennar (LEN), D.R. Horton (DHI) and NVR (NVR) initiated with a Buy and KB Home (KBH), PulteGroup (PHM), Hovnanian (HOV) and Toll Brothers (TOL) initiated with a Neutral at Buckingham. 5. VMware (VMW) reinstated with a Neutral at Goldman SachsThis list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/19
JEFF
01/17/19
DOWNGRADE
JEFF
Hold
Ubisoft downgraded to Hold from Buy at Jefferies
Jefferies analyst Timothy O'Shea downgraded Ubisoft to Hold.
01/30/19
GSCO
01/30/19
INITIATION
GSCO
Neutral
Ubisoft initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng started Ubisoft with a Neutral rating and EUR 81 price target. Ubisoft, among its video game peers, generates a smaller share of bookings from digital, in-game spending, and mobile, resulting in lower EBIT margins, Ng tells investors in a research note. Further, he believes the company's valuation is high relative to peers and that its near-term growth opportunities are well understood.

TODAY'S FREE FLY STORIES

TNXP

Tonix Pharmaceuticals

$0.45

0.0048 (1.07%)

17:12
10/18/19
10/18
17:12
10/18/19
17:12
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$20.18

1.07 (5.60%)

17:10
10/18/19
10/18
17:10
10/18/19
17:10
Syndicate
Breaking Syndicate news story on Relmada Therapeutics »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
10/18/19
10/18
16:55
10/18/19
16:55
General news
Breaking General news story  »

Dallas Federal Reserve…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

, NWS

News Corp

$13.79

-0.11 (-0.79%)

16:51
10/18/19
10/18
16:51
10/18/19
16:51
Periodicals
Facebook reaches pact with News Corp., others for news section, WSJ says »

News Corp. (NWSA) has…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

NWS

News Corp

$13.79

-0.11 (-0.79%)

FB

Facebook

$185.96

-4.435 (-2.33%)

NYT

New York Times

$29.76

0.21 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

WAIR

Wesco Aircraft

$11.01

0.01 (0.09%)

16:46
10/18/19
10/18
16:46
10/18/19
16:46
Conference/Events
Wesco Aircraft to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:41
10/18/19
10/18
16:41
10/18/19
16:41
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix up 7.5% at $3.35…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

POAI

Predictive Oncology

$0.44

0.0101 (2.35%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Conference/Events
Predictive Oncology to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BK

BNY Mellon

$45.34

0.975 (2.20%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
BNY Mellon SVP Harris sells 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Foamix 

Foamix trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

BAC

Bank of America

$30.37

0.1 (0.33%)

16:35
10/18/19
10/18
16:35
10/18/19
16:35
Hot Stocks
Bank of America's Knox sells 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Jan

LGC

Legacy Acquisition Corp

$10.24

0.02 (0.20%)

16:34
10/18/19
10/18
16:34
10/18/19
16:34
Conference/Events
Legacy Acquisition Corp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFGP

Micro Focus

$15.13

0.56 (3.84%)

, OTEX

OpenText

$39.30

-1.545 (-3.78%)

16:33
10/18/19
10/18
16:33
10/18/19
16:33
Periodicals
OpenText weighing takeover bid for rival Micro Focus, Bloomberg says »

Open Text (OTEX) is…

MFGP

Micro Focus

$15.13

0.56 (3.84%)

OTEX

OpenText

$39.30

-1.545 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

16:30
10/18/19
10/18
16:30
10/18/19
16:30
Options
Preliminary option volume of 21.9M today »

Preliminary option volume…

BA

Boeing

$344.01

-25.12 (-6.81%)

, ORCL

Oracle

$54.55

-0.52 (-0.94%)

16:22
10/18/19
10/18
16:22
10/18/19
16:22
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. earnings have…

BA

Boeing

$344.01

-25.12 (-6.81%)

ORCL

Oracle

$54.55

-0.52 (-0.94%)

KO

Coca-Cola

$54.78

0.98 (1.82%)

AXP

American Express

$116.82

-2.35 (-1.97%)

JNJ

Johnson & Johnson

$127.73

-8.47 (-6.22%)

M

Macy's

$15.11

-0.66 (-4.19%)

LB

L Brands

$16.32

-1.78 (-9.83%)

GPS

Gap

$16.87

-0.71 (-4.04%)

LEVI

Levi Strauss

$17.12

0.07 (0.41%)

DERM

Dermira

$7.17

1.49 (26.23%)

ETFC

E-Trade

$40.82

1.78 (4.56%)

GIL

Gildan Activewear

$26.29

-9.085 (-25.68%)

TEAM

Atlassian

$116.96

-5.47 (-4.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 31

    Oct

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 06

    Dec

  • 07

    Dec

EYEG

EyeGate

$3.40

(0.00%)

16:20
10/18/19
10/18
16:20
10/18/19
16:20
Syndicate
Breaking Syndicate news story on EyeGate »

EyeGate files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/18/19
10/18
16:20
10/18/19
16:20
Options
Closing CBOE SPX and VIX Index summary for October 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$20.36

0.36 (1.80%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Hot Stocks
Glenview Capital discloses 14.7% activist stake in Meritor »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BCBP

BCB Bancorp

$12.91

-0.04 (-0.31%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Earnings
BCB Bancorp reports Q3 EPS 30c, consensus 30c »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
10/18/19
10/18
16:16
10/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$5.35

0.12 (2.29%)

16:15
10/18/19
10/18
16:15
10/18/19
16:15
Syndicate
Breaking Syndicate news story on Universal Technical »

Universal Technical files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$246.37

2.62 (1.07%)

16:13
10/18/19
10/18
16:13
10/18/19
16:13
Hot Stocks
UnitedHealth's Burke sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:09
10/18/19
10/18
16:09
10/18/19
16:09
Hot Stocks
Foamix announces FDA approval of AMZEEQ topical foam, 4% »

Foamix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

KWR

Quaker Chemical

$160.98

-2.04 (-1.25%)

16:05
10/18/19
10/18
16:05
10/18/19
16:05
Earnings
Quaker Houghton sees Q3 net sales $325M, consensus $348.82M »

Michael F. Barry,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KWR

Quaker Chemical

$160.98

-2.04 (-1.25%)

16:05
10/18/19
10/18
16:05
10/18/19
16:05
Earnings
Quaker Houghton sees FY19 pro forma adjusted EBITDA down 2%-4% »

Quaker Houghton updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.